NEW Our free Dividend Tracker is live — see what your stocks pay you

Add your stocks and see every dividend they pay you — dates, amounts, and reinvested shares.

Start Free »

SOLV | NYSE

$83.56 $1.71 | 2.09%

TREND SIGNAL: Signal available — unlock to view

|2026-10-07

Next Earnings: Nov 05, 2026

Add to favoritesFavorite

Company Overview:

Market Cap: $14.50B

Trailing PE: 10.2x

FWD PE *: 12.3x

Payout Ratio (TTM): —

52-Week Range: $62.38 - $94.16

* Forward PE is based on street estimates.

2.6 Year SOLV Performance Metrics:

Total Return (with DRIP): 20.9% (7.58% CAGR)

Total Return (no DRIP): 20.9% (7.58% CAGR)

Share Price: 20.9% (7.58% CAGR)

Yield on Cost (with DRIP): —

Total Invested: $10,000

Total Value (with DRIP): $12,093

Total Return $ (with DRIP): $2,093

SOLV Total Return

1M 3M 6M YTD 1Y 3Y 5Y 10Y

SOLV Price Chart

1M 3M 6M YTD 1Y 3Y 5Y 10Y All

Build Custom Charts

SOLV - Chart 1

SOLV - Chart 2

SOLV - Chart 3

Unlock All Reports & Research Dividend Stocks like a BOSS!

Get 3 Months Free with Annual Plan

PRO

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Buy/Sell Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

Combined 55% Lifetime Discount

SOLV Financials: Earnings, Revenue, Cash Flow, Ebitda, Cash/Debt, Shares Float, etc:

SOLV - Revenue

SOLV Revenue CAGR:1Y: 2.22%2Y: 3.03%5Y: 0.00%10Y: 0.00%

SOLV - Earnings Per Share (EPS)

SOLV EPS CAGR:1Y: 3.92%2Y: 1.94%5Y: 0.00%10Y: 0.00%

SOLV - Net Income

🔓 See the full chart40% off right now · 7-day free trial

SOLV Net Income CAGR:1Y: 2.22%2Y: 1.67%5Y: 0.00%10Y: 0.00%

SOLV - EBITDA

🔓 See the full chart40% off right now · 7-day free trial

SOLV EBITDA CAGR:1Y: -47.56%2Y: -29.19%5Y: 0.00%10Y: 0.00%

SOLV - Free Cash Flow

🔓 See the full chart40% off right now · 7-day free trial

SOLV Free Cash Flow CAGR:1Y: 144.07%2Y: -30.37%5Y: 0.00%10Y: 0.00%

SOLV - Free Cash Flow / Share

🔓 See the full chart40% off right now · 7-day free trial

SOLV Free Cash Flow / Share CAGR:1Y: 144.91%2Y: -30.43%5Y: 0.00%10Y: 0.00%

SOLV - Operating Income

🔓 See the full chart40% off right now · 7-day free trial

SOLV Operating Income CAGR:1Y: -15.42%2Y: -13.87%5Y: 0.00%10Y: 0.00%

SOLV - Gross Profit

🔓 See the full chart40% off right now · 7-day free trial

SOLV Gross Profit CAGR:1Y: 9.45%2Y: 6.35%5Y: 0.00%10Y: 0.00%

SOLV - Shares Outstanding

🔓 See the full chart40% off right now · 7-day free trial

SOLV Shares Outstanding CAGR:1Y: -0.46%2Y: 0.26%5Y: 0.00%10Y: 0.00%

SOLV - Share Buybacks

🔓 See the full chart40% off right now · 7-day free trial

SOLV Share Buybacks CAGR:1Y: 0.00%2Y: 0.00%5Y: 0.00%10Y: 0.00%

SOLV - Stock-Based Comp

🔓 See the full chart40% off right now · 7-day free trial

SOLV Stock-Based Comp CAGR:1Y: 11.76%2Y: -17.62%5Y: 0.00%10Y: 0.00%

SOLV - Expenses

🔓 See the full chart40% off right now · 7-day free trial

SOLV Expenses CAGR:1Y: -24.55%2Y: 19.63%5Y: 0.00%10Y: 0.00%

SOLV - Revenue vs Net Income

🔓 See the full chart40% off right now · 7-day free trial

SOLV - EPS vs FCF / Share

🔓 See the full chart40% off right now · 7-day free trial

SOLV - EPS vs PE Ratio

🔓 See the full chart40% off right now · 7-day free trial

SOLV - FCF vs FCF / Share

🔓 See the full chart40% off right now · 7-day free trial

SOLV - FCF vs Stock Based Comp

🔓 See the full chart40% off right now · 7-day free trial

SOLV - Cash & Debt

🔓 See the full chart40% off right now · 7-day free trial

SOLV - Revenue by Segment

🔓 See the full chart40% off right now · 7-day free trial

SOLV Revenue CAGR:1Y: 2.22%2Y: 3.03%5Y: 0.00%10Y: 0.00%

SOLV - Revenue by Region

🔓 See the full chart40% off right now · 7-day free trial

SOLV Revenue CAGR:1Y: 2.22%2Y: 3.03%5Y: 0.00%10Y: 0.00%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

SOLV - REVENUE: Actual + Estimates

🔓 See the full chart40% off right now · 7-day free trial

SOLV Actual Revenue CAGR:1Y: 2.22%2Y: 3.03%5Y: 0.00%10Y: 0.00%

SOLV - EPS: Actual + Estimates

🔓 See the full chart40% off right now · 7-day free trial

SOLV Actual EPS CAGR:1Y: 3.92%2Y: 1.94%5Y: 0.00%10Y: 0.00%

SOLV - NET INCOME: Actual + Estimates

🔓 See the full chart40% off right now · 7-day free trial

SOLV Actual Net Income CAGR:1Y: 2.22%2Y: 1.67%5Y: 0.00%10Y: 0.00%

SOLV - EBITDA: Actual + Estimates

🔓 See the full chart40% off right now · 7-day free trial

SOLV Actual EBITDA CAGR:1Y: -47.56%2Y: -29.19%5Y: 0.00%10Y: 0.00%

Ratios, Profit Margins & Return on Capital:

SOLV - Net Profit Margin

🔓 See the full chart40% off right now · 7-day free trial

SOLV Net Profit Margin CAGR:1Y: 0.00%2Y: -1.41%5Y: 0.00%10Y: 0.00%

SOLV - Gross Profit Margin

🔓 See the full chart40% off right now · 7-day free trial

SOLV Gross Profit Margin CAGR:1Y: 7.08%2Y: 3.22%5Y: 0.00%10Y: 0.00%

SOLV - Price to Earnings

🔓 See the full chart40% off right now · 7-day free trial

SOLV Price to Earnings CAGR:1Y: -0.19%2Y: 20.58%5Y: 0.00%10Y: 0.00%

SOLV - Price To Sales Ratio

🔓 See the full chart40% off right now · 7-day free trial

SOLV Price To Sales Ratio CAGR:1Y: -0.83%2Y: 18.96%5Y: 0.00%10Y: 0.00%

SOLV - Return on Capital Employed

🔓 See the full chart40% off right now · 7-day free trial

SOLV Return on Capital Employed CAGR:1Y: -0.44%2Y: -8.25%5Y: 0.00%10Y: 0.00%

SOLV - Return on Invested Capital

🔓 See the full chart40% off right now · 7-day free trial

SOLV Return on Invested Capital CAGR:1Y: -6.36%2Y: -13.61%5Y: 0.00%10Y: 0.00%

Projected Future Returns & Dividends for SOLV

Based on past 2.6-year performance, here are SOLV growth metrics:

Share price CAGR of +7.58%
Dividend CAGR of +0%

Using SOLV CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

	SOLV (DRIP)	SOLV - No DRIP
Current Price	$83.56	$83.56
Start Shares	119.67	119.67
Start Value	$10,000	$10,000

After 10 years:
Final Share Count	119.67	119.67
Dividends Payment	$0.00	$0.00
Annual Dividends	$0	$0
Yield on cost	0.00%	0.00%
Share Price	$83.56	$83.56
Total Dividends	$0	$0
Final Value	$10,000	$10,000

Estimated Future Value + Dividends - SOLV

NOTE: Above numbers are our estimate based on SOLV's Dividend and Price CAGR over past 2.6 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Get 3 Months Free with Annual Plan

PRO

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Buy/Sell Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

Combined 55% Lifetime Discount

Company Info

Solventum Corporation (SOLV) had its IPO on 2024-04-01, and is traded on NYSE stock exchange.

Solventum Corporation, established in 2023 and headquartered in Saint Paul, Minnesota, operates as a healthcare entity dedicated to pioneering, producing, and commercializing diverse solutions that address critical needs for both customers and patients. The company's business activities are organized into four principal segments. The Medsurg division furnishes various products and services, including sophisticated wound care items, intravenous (I.V.) site management tools, sterilization assurance systems, temperature regulation devices, surgical instruments, stethoscopes, and medical electrodes. Its Dental Solutions segment provides a comprehensive range of dental and orthodontic offerings, such as brackets, clear aligners, restorative filling materials, and bonding agents. The Health Information Systems division concentrates on advanced software platforms, covering functionalities like computer-assisted physician documentation, direct billing and coding automation, classification frameworks, voice recognition capabilities, and data visualization tools. Finally, the Purification and Filtration segment supplies an array of purification and filtration technologies, including various filters, purifiers, cartridges, and specialized membranes.

SOLV website: https://www.solventum.com

Get Full Access to All Reports with DRIPCalc PRO

Get 3 Months Free with Annual Plan

PRO

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Buy/Sell Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

Combined 55% Lifetime Discount

DCF Model — SOLV

Value from:

EPS (TTM)icompany profit per share over the last 12 months

EPS Growth %ihow fast profit per share grows each of the next 5 years — prefilled with what analysts expect

EPS growth after year 5 (forever)ithe slower pace once the fast 5 years are over — only drives years 6-10 of the price path below

Exit multiple (PE in 5 yrs)iwhat buyers pay per $1 of profit in 2031 — prefilled with today’s forward PE

Desired return %/yrithe yearly return you want from buying today — the S&P has done ~14%/yr, ask for more from a single stock

FCF growth %/yr (next 5 yrs)ihow fast free cash flow grows while the company is still expanding fast

Years of fast FCF growthihow many years the fast growth lasts before the business settles down

FCF growth after year 5 (forever)ithe slow, steady pace once the company is mature — usually 2-3%, near inflation. Must stay below your target return

Risk-free rate %iwhat a 10-yr US treasury pays with zero risk — the floor any risky stock must beat

Your target return %/yrithe yearly return you want for taking this risk — rule of thumb: risk-free rate + extra for risk

FCF base ($M, TTM)ilast 12 months of free cash flow, added up from reported quarters

Include dividends in returnidividends hand you part of the return in cash, so the share price needs to climb less

Pay up to today

—

vs current price $83.56

—

Cash flow & implied price by year

FCF is negative or missing for this company (common for banks) — the model discounts EPS instead.

EPS is negative or missing for this company — Simple mode uses free cash flow per share instead.

Free cash flow today

—

grows for the next years

Then mature

—

every future dollar counted back to today

Pile of today-dollars

—

÷ shares

Implied price path

Year	FCF	Implied price

Sensitivity — fair value: growth ↓ × target return →